AVEO Pharmaceuticals (NASDAQ: AVEO) reported Q2 EPS of ($0.35), $0.09 better than the analyst estimate of ($0.44).

For earnings history and earnings-related data on AVEO Pharmaceuticals (AVEO) click here.